# Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

> **NCT00003580** · PHASE2 · COMPLETED · sponsor: **University of Tennessee**

## Conditions studied

- Drug/Agent Toxicity by Tissue/Organ
- Head and Neck Cancer
- Oral Complications
- Radiation Toxicity

## Interventions

- **DRUG:** amifostine trihydrate
- **DRUG:** cisplatin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003580
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003580, "Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00003580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*